Consolidation Surge: Key Healthcare Mergers and Acquisitions in 2024
Credit:- Sugandh Khandelwal 2024 has been a transformational year for the healthcare sector in India, with mergers and acquisitions (M&A)…
Economics
Read Global and Indian Healthcare Economics and Market news with TISHHA. Fastest coverage of all aspects related to industry deals, policies, plans, mergers and much more
Read More
Reliance Acquires Karkinos Healthcare in ₹375 Crore All-Cash Deal
Reliance Industries Ltd (RIL), led by billionaire Mukesh Ambani, traded flat in early deals on Monday despite announcing the acquisition…
India’s healthcare sector is projected to reach US$ 320 billion (Rs. 27,28,320 crore) by 2028, according to a recent report
India’s healthcare sector is projected to reach US$ 320 billion (Rs. 27,28,320 crore) by 2028, according to a recent report…
Mankind Pharma and Innovent Collaborate to Improve Cancer Care Access in India
Mankind Pharma has announced a strategic partnership with Innovent Biologics to introduce Sintilimab, a PD-1 immunotherapy, to the Indian market….
The claims ratio of non-life insurers has dropped to 82.52% in the FY2023-24
The annual report from the Insurance Regulatory and Development Authority of India (IRDAI) has raised concerns about the declining insurance…
2024 IPO Boom: India’s Healthcare and Pharma Sectors Secure ₹14,811 Crore – A Five-Year High In 2024
Credit:- Sugandh Khandelwal India’s healthcare and pharmaceutical sectors raised ₹14,811 crore through initial public offerings (IPOs), marking the highest annual…
IKS Health’s ₹2,500 Crore IPO to Propel Expansion in US Healthcare Market
IKS Health (Inventurus Knowledge Solutions Ltd) , a leading provider of administrative solutions for healthcare organizations and backed by Rekha…
Temasek becomes largest shareholder in Manipal Health
Credit:- Sugandh Khandelwal Manipal Health Enterprises has been successfully acquired by Temasek, which now holds a majority stake. Temasek now…
EQT Asia Surpasses $5 Billion Investment Target in India
EQT Asia has exceeded its original investment target of $5 billion in India over the past few years, according to…
Suraksha Diagnostics’ shares open to a lukewarm response: ending over 5% down on debut
Suraksha Diagnostics’ stock opened at ₹437 and ₹438 on the BSE & NSE respectively, slipping 0.90% & 0.68% respectively below…